Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Buy GSK Shares
Add GSK to Watchlist
Add GSK to Alert

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,610.00

Bid: 1,609.50

Ask: 1,610.50

Change: 12.00 (0.75%)

Spread: 1.00 (0.062%)

Open: 1,595.00

High: 1,626.00

Low: 1,588.00

Prev. Close: 1,598.00

Last checked at -

BROKER RATINGS SUMMARY: Merrill Lynch, JPMorgan Cut Pearson To Neutral

Thu, 22nd Oct 2015 08:40

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning:
----------
FTSE 100
----------
MERRILL LYNCH CUTS PEARSON TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS PEARSON TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 1,080 (1,365) PENCE
----------
KEPLER CHEUVREUX CUTS PEARSON PRICE TARGET TO 1300 (1400) PENCE - 'BUY'
----------
NOMURA CUTS PEARSON PRICE TARGET TO 1100 (1280) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK CUTS PEARSON PRICE TARGET TO 950 (1045) PENCE - 'SELL'
----------
JEFFERIES RAISES RECKITT BENCKISER PRICE TARGET TO 7100 (6750) PENCE - 'BUY'
----------
LIBERUM RAISES RECKITT BENCKISER PRICE TARGET TO 6800 (6660) PENCE - 'BUY'
----------
EXANE BNP RAISES RECKITT BENCKISER PRICE TARGET TO 6900 (6600) PENCE - 'OUTPERFORM'
----------
DEUTSCHE BANK RAISES RECKITT BENCKISER PRICE TARGET TO 6500 (6400) PENCE - 'BUY'
----------
PANMURE CUTS TRAVIS PERKINS PRICE TARGET TO 1650 (1950) PENCE - 'SELL'
----------
EXANE BNP RAISES SKY PLC PRICE TARGET TO 1050 (1000) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1420) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1300 (1360) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES ARM PRICE TARGET TO 950 (850) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS HSBC PRICE TARGET TO 640 (670) PENCE - 'NEUTRAL'
----------
FTSE 250
----------
PANMURE CUTS SIG PRICE TARGET TO 195 (226) PENCE - 'BUY'
----------
PANMURE CUTS SENIOR PLC TO 'HOLD' ('BUY') - TARGET 293 (402) PENCE
----------
JPMORGAN CUTS ACACIA MINING PRICE TARGET TO 300 (310) PENCE - 'OVERWEIGHT'
----------
EXANE BNP CUTS HOME RETAIL PRICE TARGET TO 115 (145) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS HOME RETAIL PRICE TARGET TO 130 (150) PENCE - 'HOLD'
----------
NOMURA CUTS HOME RETAIL PRICE TARGET TO 170 (200) PENCE - 'BUY'
----------
HSBC CUTS HOME RETAIL PRICE TARGET TO 1,800 (2,350) PENCE - 'BUY'
----------
HSBC CUTS PENNON GROUP PRICE TARGET TO 9,150 (9,500) PENCE - 'BUY'
----------
GOLDMAN RAISES TED BAKER PRICE TARGET TO 3560 (3530) PENCE - 'BUY'
----------
GOLDMAN RAISES SHAWBROOK PRICE TARGET TO 390 (370) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES PROVIDENT FINANCIAL PRICE TARGET TO 3370 (2970) PENCE - NEUTRAL
----------
GOLDMAN RAISES POLYMETAL PRICE TARGET TO 620 (570) PENCE - 'BUY'
----------
GOLDMAN INITIATES CENTAMIN WITH 'CONVICTION BUY LIST'
----------
TRADERS: CREDIT SUISSE CUTS HAYS TO 'NEUTRAL' ('OUTPERFORM')
----------
MAIN MARKET AND AIM
----------
NUMIS RAISES MOTHERCARE TO 'BUY' ('ADD') - TARGET 300 (320) PENCE
----------
NUMIS CUTS CAMBIAN PRICE TARGET TO 320 (380) PENCE - 'BUY'
----------
JPMORGAN RAISES LONMIN PRICE TARGET TO 35 (30) PENCE - 'OVERWEIGHT'
----------
GOLDMAN CUTS ARROW GLOBAL PRICE TARGET TO 360 (380) PENCE - 'BUY'
----------
TRADERS: CREDIT SUISSE CUTS STHREE TO 'NEUTRAL' ('OUTPERFORM')
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News

3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Latest Share Chat

Glaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Merrill Lynch, JPMorgan Cut Pearson To Neutral

Login to your account

Quickpicks are a member only feature

Login to your account